GPR143 in melanocytes and retinal pigment epithelium cells

No Pathway Network information available for GPR143 in melanocytes and retinal pigment epithelium cells

Pathways in the GPR143 in melanocytes and retinal pigment epithelium cells SuperPath

Ordered by rank within the SuperPath, via the multiplicity of each gene in the constituent pathways

Disorders associated with GPR143 in melanocytes and retinal pigment epithelium cells SuperPath

according to GeneCards Suite gene sharing
#DisorderTypeGenesScore
1AlbinismEnrichmentDCT, GPR143, TYR, TYRP19.58
2Albinism, ocular, type iEnrichmentGPR143, TYR, TYRP16.76
3Melanoma, cutaneous malignant 8EnrichmentMITF, TYR5.36
4Albinism, oculocutaneous, type iiEnrichmentMC1R, TYRP14.36
5Waardenburg syndrome, type 2eEnrichmentMITF, TYR4.04
6Oculocutaneous albinismEnrichmentTYR, TYRP14.04
7Ellis-van creveld syndromeEnrichmentPRKACA, PRKACB3.80
8MelanomaEnrichmentMC1R, MITF3.71
9Melanoma, cutaneous malignant 1EnrichmentMC1R, MITF3.23
10Nystagmus 6, congenital, x-linkedEnrichmentGPR1432.67
11Albinism, oculocutaneous, type ibEnrichmentTYR2.67
12Pseudohypoparathyroidism, type icEnrichmentGNAS2.67
13Osseous heteroplasia, progressiveEnrichmentGNAS2.67
14Heterochromia iridisEnrichmentMITF2.67
15Tietz albinism-deafness syndromeEnrichmentMITF2.67
16Increased analgesia from kappa-opioid receptor agonist, female-specificEnrichmentMC1R2.67
17Sturge-weber syndromeEnrichmentGNAQ2.67
18Acth-independent macronodular adrenal hyperplasia 1EnrichmentGNAS2.67
19Skin/hair/eye pigmentation, variation in, 3EnrichmentTYR2.67
20Spondylometaphyseal dysplasia with corneal dystrophyEnrichmentPLCB32.67
21Pituitary adenoma 3, multiple typesEnrichmentGNAS2.67
22Skin/hair/eye pigmentation, variation in, 2EnrichmentMC1R2.67
23Cardioacrofacial dysplasia 2EnrichmentPRKACB2.67
24Coloboma, osteopetrosis, microphthalmia, macrocephaly, albinism, and deafnessEnrichmentMITF2.67
25Microvascular complications of diabetes 1EnrichmentVEGFA2.67
26Pigmented nodular adrenocortical disease, primary, 4EnrichmentPRKACA2.67
27Melanoma, cutaneous malignant 5EnrichmentMC1R2.67
28Skin/hair/eye pigmentation, variation in, 9EnrichmentASIP2.67
29Disorders of gnas inactivationEnrichmentGNAS2.67
30Cardioacrofacial dysplasia 1EnrichmentPRKACA2.67
31Minimal pigment oculocutaneous albinism type 1EnrichmentTYR2.67
32Monostotic fibrous dysplasiaEnrichmentGNAS2.67
33Mazabraud syndromeEnrichmentGNAS2.67
34Hypopigmentation of the skinEnrichmentTYR2.67
35Spinocerebellar ataxia 29EnrichmentITPR12.37
36Pseudohypoparathyroidism, type iaEnrichmentGNAS2.37
37Albinism, oculocutaneous, type iiiEnrichmentTYRP12.37
38Histiocytoma, angiomatoid fibrousEnrichmentCREB12.37
39Pigmented nodular adrenocortical disease, primary, 1EnrichmentGNAS2.37
40PseudopseudohypoparathyroidismEnrichmentGNAS2.37
41Bleeding disorder, platelet-type, 19EnrichmentPRKACG2.37
42Albinism, oculocutaneous, type iaEnrichmentTYR2.37
43Skin/hair/eye pigmentation, variation in, 11EnrichmentTYRP12.37
44Oculocutaneous albinism, type viiiEnrichmentDCT2.37
45PseudohypoparathyroidismEnrichmentGNAS2.37
46Papillary renal cell carcinomaEnrichmentMITF2.37
47Fibrolamellar carcinomaEnrichmentPRKACA2.37
48Acth-independent macronodular adrenal hyperplasiaEnrichmentGNAS2.37
49Phakomatosis cesioflammeaEnrichmentGNAQ2.37
50Body mass index quantitative trait locus 11EnrichmentGNAS, POMC2.29
51Mccune-albright syndromeEnrichmentGNAS2.19
52Waardenburg syndrome, type 2aEnrichmentMITF2.19
53Gillespie syndromeEnrichmentITPR12.19
54Obesity, early-onset, with adrenal insufficiency and red hairEnrichmentPOMC2.19
55Osteogenesis imperfecta, type viEnrichmentSERPINF12.19
56Cushing syndrome due to bilateral macronodular adrenocortical diseaseEnrichmentGNAS2.19
57Melanoma of soft tissueEnrichmentCREB12.19
58Anastomosing haemangiomaEnrichmentGNAQ2.19
59Obesity due to pro-opiomelanocortin deficiencyEnrichmentPOMC2.19
60Pseudohypoparathyroidism, type ibEnrichmentGNAS2.07
61Spinocerebellar ataxia 15EnrichmentITPR12.07
62Clear cell papillary renal cell carcinomaEnrichmentMITF2.07
63Capillary malformations, congenitalEnrichmentGNAQ1.97
64Klippel-trenaunay-weber syndromeEnrichmentGNAQ1.89
65Melanoma, uvealEnrichmentGNAQ1.89
66Waardenburg syndrome, type 4aEnrichmentMITF1.89
67Spinocerebellar ataxia, autosomal recessive 16EnrichmentITPR11.89
68Waardenburg syndromeEnrichmentMITF1.89
69Waardenburg syndrome, type 1EnrichmentMITF1.83
70BrachydactylyEnrichmentGNAS1.83
71Spastic paraplegia 4, autosomal dominantEnrichmentGNAS1.77
72Primary hyperaldosteronismEnrichmentGNAS1.72
73Optic nerve diseaseEnrichmentTYR1.67
74Osteogenesis imperfecta, type ivEnrichmentSERPINF11.56
75Multiple sclerosisEnrichmentITPR11.53
76Osteogenesis imperfecta, type iiiEnrichmentSERPINF11.50
77MyopiaEnrichmentTYR1.50
78Anterior segment dysgenesisEnrichmentITPR11.50
79Skin diseaseEnrichmentTYR1.34
80Brittle bone disorderEnrichmentSERPINF11.32
81Ear malformationEnrichmentMITF1.30
82StrabismusEnrichmentTYR1.25
83Eye diseaseEnrichmentTYR1.14
84Non-syndromic genetic deafnessEnrichmentMITF1.13
85Nonsyndromic hearing lossEnrichmentMITF1.07
86Rare autosomal dominant non-syndromic sensorineural deafness type dfnaEnrichmentMITF0.98
87Spastic ataxiaEnrichmentITPR10.97
88Hereditary breast ovarian cancer syndromeEnrichmentMITF0.95
89Rare genetic deafnessEnrichmentMITF0.81
90Inherited cancer-predisposing syndromeEnrichmentMITF0.61

Loading...
Loading...
Loading...